top of page

Alexa Briefing

A brief overview of GLP-1 RA's and their role in DM2 therapy.

Some take-away points from the ACCOMPLISH Trial

A quick review of the evidence-based beta-blockers that are used in HFrEF.

Entresto - A review of the ARNI approved for the treatment of HFrEF.

Just a quick overview of the new subcutaneous version of buprenorphine that is administered only once monthly.

A quick discussion about the potential harms of atenolol when used for the treatment of hypertension.

I review the results of the DARE Trial and provide a strategy for helping patients with diabetes see the importance of exercise.

A very quick review of the RALES trial. RALES looked at spironolactone use in patients with HFrEF.

This is a brief discussion of the Remicade biosimilars that have been approved. I also discuss the FDA's Purple Book.

A brief discussion on using letermovir as prophylaxis against CMV in patients that have undergone hematopoietic stem cell transplantation.

bottom of page